Tessera Therapeutics

Tessera Therapeutics

MA - Somerville
Biotechnology4 H-1B visas (FY2023)

Focus: Gene Writing

Tessera Therapeutics is a life sciences company focused on Gene Writing.

Rare DiseasesGene Therapy
Open Jobs
2

Pipeline & Clinical Trials

Clinical Trials (1)
NCT07227207A Study of TSRA-196 in Adults With PiZZ Alpha-1 Antitrypsin Deficiency (AATD)
Phase 1/2

Open Jobs (2)

Interview Prep Quick Facts
Portfolio: 1 clinical trial
H-1B (2023): 4 approvals
Open Roles: 2 active jobs

Hiring Trend

Stable
2
Open Roles
+0
Added
-2
Filled/Removed

Based on last 4 crawl cycles

Visa Sponsorship

Sponsors Work Visas
H-1B Petitions (FY2023)
4
Approved
1
Denied
80%
Rate

Source: USCIS H-1B Employer Data Hub